{"id":13143,"date":"2020-01-28T09:37:46","date_gmt":"2020-01-28T08:37:46","guid":{"rendered":"https:\/\/www.gsk.de\/?p=13143"},"modified":"2021-09-08T14:42:32","modified_gmt":"2021-09-08T12:42:32","slug":"gsk-stockmann-advises-e-scooter-supplier-circs-investors-on-takeover-by-bird","status":"publish","type":"post","link":"https:\/\/gsk.de\/en\/gsk-stockmann-advises-e-scooter-supplier-circs-investors-on-takeover-by-bird\/","title":{"rendered":"GSK Stockmann advises e-scooter supplier Circ\u2019s investors on takeover by Bird"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>GSK Stockmann provided comprehensive legal\nadvice to the investors of the e\u2011scooter company Circ, Team Europe, Target\nGlobal and Idinvest Partners, on the takeover by U.S. micro-mobility provider\nBird. The parties agreed not to disclose the purchasing price.<\/strong><strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Founded in August 2018 by Lukasz Gadowski, Circ is one of the leading e-scooter companies in Europe and the Middle East and has now deployed its scooters to 43 cities in 12 countries. The takeover by U.S. e-scooter rental company Bird, founded by Travis VanderZanden, formerly working for Uber, was completed as a cross-border share deal in conjunction with a joint financing round and the corporate restructuring of Circ. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bird and Circ intend to use their combined\ntechnological and innovative capabilities to further expand and enhance the\nrange of climate-friendly micro-mobility solutions offered in cities. Besides\nthe investors Team Europe, Target Global and Idinvest Partners that GSK\nStockmann advised, well-known VC investors such as Sequoia Capital, Index\nVentures, Accel and Valor Equity Partners are also part of the joint\nventure.&nbsp; <strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A GSK Stockmann team led by Partner Katy Ritzmann\n(Berlin) provided comprehensive advice to the Circ investors on all legal\nissues relating to the reorganisation, the financing and the takeover.\nThroughout this process, the firm was able to showcase its expertise available\nin its Sectors Mobility and Financial Services as well as in its special VC\/PE\nand IT\/IP Competency Fields. GSK Stockmann also drew on its many years of\nexperience in transactions and financing advice to both investors and young\ncompanies and their founders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This complex international process (Germany,\nLuxembourg and the U.S.) was successfully concluded within just a few weeks\nthanks to close cooperation with GSK Stockmann\u2019s Luxembourg office and select\ninternational law firms.&nbsp; <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Advisers of Team Europe, Target Global,\nIdinvest Partners:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>GSK Stockmann:<\/strong> Katy Ritzmann (VC\/PC, IP\/IT, lead), Mathilde Ostertag (Tax);\nAssociates: Dennis Gehnen (IP\/IT, VC\/PC), Ira Mie\u00dfler (IP\/IT)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GSK Stockmann provided comprehensive legal advice to the investors of the e\u2011scooter company Circ, Team Europe, Target Global and Idinvest Partners, on the takeover by U.S. micro-mobility provider Bird.<\/p>\n","protected":false},"author":32,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[402],"tags":[],"ausgabe":[675],"verknuepfung":[759,766,776,779],"class_list":["post-13143","post","type-post","status-publish","format-standard","hentry","category-deal-news","ausgabe-gsk","verknuepfung-financial-services","verknuepfung-ip-it-en","verknuepfung-mobility-en","verknuepfung-private-equity-venture-capital-en"],"acf":{"ansprechpartner":[{"anwalt":1001}],"postdownloads":[{"download":false,"anzeigetitel":""}]},"info":{"date":"28.01.2020","author":"GSK Sysop","categories_names":["Deal News"],"category":"Deal News"},"wpml_main_post_id":13107,"featured_img_src":"","_links":{"self":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/13143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/comments?post=13143"}],"version-history":[{"count":0,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/13143\/revisions"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/media?parent=13143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/categories?post=13143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/tags?post=13143"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/ausgabe?post=13143"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/verknuepfung?post=13143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}